Medical data informatics company Clinerion will expand its Patient Network Explorer (PNEx) to hospitals and clinical trial sites in Uruguay after partnering with clinical development service provider Eugen.
Under the partnership, Eugen will encourage hospitals in the country to join PNEx. Both companies intend to use PNEx to provide clients with real patient health data insights while choosing their clinical trial’s geographic distribution.
They will also provide better trial design tools and ensure effective patient enrolment.
Both companies said that hospitals in Uruguay will be able to increase their visibility and attract global multicentric trials while providing innovative treatments to patients.
Clinerion CEO Ian Rentsch said: “This partnership is true to Clinerion’s aim of bringing the most modern treatments to patients around the world.
“Joining the Patient Network Explorer platform, sites in Uruguay will become more visible for trial sponsors making site selection decisions. As a result, patients in Uruguay will gain access to leading-edge international trials matching their treatment needs.”
Eugen creates an ecosystem to benefit biopharma companies and provide the best clinical development programmes to patients to increase the flow of clinical trials to Latin America.
The country recently pioneered medical and recreative cannabis regulation and revamped its clinical research regulation.
Eugen operations director Claudia Rodriguez Verde said: “In this context, our partnership with Clinerion couldn’t be timelier as Uruguay has gradually shifted its economic model to transform itself into a centre of innovation in Latin America.
“Clinerion’s Patient Network Explorer is already reshaping drug development worldwide and brings to Uruguay and Latin America the new models of clinical trials that use data and artificial intelligence.
“We are very enthusiastic about this partnership and we are certain it will leverage Uruguay’s efforts to be at the forefront of clinical research, as well as being a meaningful step to provide Eugen’s customers with precise data generated in real-time.”